Membrane transporters for thyroid hormone
Current Opinion in Endocrinology and Diabetes , Volume 12 - Issue 5 p. 371- 380
Purpose of review: Action and metabolism of thyroid hormones are intracellular events, which require their uptake across the plasma membrane. Cellular uptake of thyroid hormone is mediated by transporters, and recently, some of these transporters have been identified at the molecular level. Here we review the biochemistry, molecular biology, and clinical relevance of these transporters. Recent findings: Iodothyronine transporters have been identified among the members of different transporter families, including Na/taurocholate cotransporting polypeptide, different (Na-independent) organic anion transporting polypeptides, the L-type amino acid transporters, and monocarboxylate tranaporter-8. Two transporters are particularly interesting: organic anion transporting polypeptide-1C1, which shows a high affinity for T4 and T3 and is almost exclusively expressed in brain, and monocarboxylate transporter-8, which is a very active iodothyronine transporter with a slight preference for T3 and is abundantly expressed in different tissues, including brain. Organic anion transporting polypeptide-1C1 is probably important for T4 transport across the blood-brain barrier and that monocarboxylate transporter-8 for T3 uptake in neurons. Recently, mutations in MCT8, which is located on the X chromosome, were identified in male patients with severe psychomotor retardation and elevated serum levels of T3. Summary: Recent studies have greatly increased our knowledge about the identity of thyroid hormone transporters and in particular their physiologic relevance. The dramatic consequences of mutations in monocarboxylate transporter-8 represent a novel mechanism of thyroid hormone resistance due to inhibited cellular entry of the hormone.
|, , , , , , ,|
|Current Opinion in Endocrinology and Diabetes|
|Organisation||Department of Internal Medicine|
Friesema, E.C.H, Jansen, J, & Visser, T.J. (2005). Membrane transporters for thyroid hormone. Current Opinion in Endocrinology and Diabetes (Vol. 12, pp. 371–380). doi:10.1097/01.med.0000178272.01741.54